NERV
Minerva Neurosciences Inc
3.40$
+0.0%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 28.3% | 40.5% | 63.1% | 70.5% | 64.7% | 60.8% | 47.6% | 80.7% | 72.9% | 73.8% | 60.0% | 84.8% | |
| 27.1% | 17.3% | 62.4% | 14.2% | 36.1% | 27.6% | 44.0% | 78.8% | 65.5% | 71.9% | 57.5% | 84.0% | |
| 27.1% | 39.0% | 62.4% | 69.8% | 63.2% | 59.2% | 44.0% | 78.8% | 65.5% | 71.9% | 57.5% | 84.0% | |
| – | – | – | – | – | – | – | – | 5.7% | – | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | -5.5% | – | – | – | |
| 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | – | 0.0% | – | – | – | |
| 21.7% | 18.0% | 11.2% | 8.1% | 10.7% | 19.2% | 25.8% | 19.3% | 27.0% | 26.1% | 40.0% | 15.2% | |
| 50.0% | 41.4% | 25.7% | 18.6% | 24.6% | 19.6% | 26.4% | 0.1% | 0.1% | 0.0% | 39,992.0% | – | |
| 24.8% | 33.0% | 20.3% | 28.4% | 35.1% | 64.2% | 8.6% | 89.7% | 136.4% | 150.0% | 169.2% | 243.7% | |
| 5.1% | 6.4% | 7.3% | 3.7% | 2.6% | 8.6% | 5.5% | 3.7% | 2.5% | 5.9% | 7.6% | 2.3% | |
| 2.1% | 1.7% | 3.7% | 2.2% | 29,593.8% | 0.2% | 0.2% | – | – | – | – | – | |
| 0.9% | 1.6% | 1.1% | 0.8% | 1.3% | 3.0% | 1.7% | 2.4% | 1.8% | 3.2% | 4.3% | 0.7% | |
| 0.0% | 10.3% | 2.9% | 0.0% | – | – | – | – | – | – | – | – | |
| 75.2% | 67.0% | 79.7% | 71.6% | 64.9% | 35.8% | 91.4% | 10.3% | -36.4% | -50.0% | -69.2% | -143.7% | |
| -109.2% | -123.3% | -99.9% | -89.5% | -154.2% | -370.0% | -494.2% | -434.0% | -665.9% | -697.4% | -1,064.4% | -703.1% | |
| 3.4% | 3.5% | 3.0% | 2.6% | 3.5% | 6.3% | 8.9% | 6.9% | 9.7% | 11.4% | 20.4% | 8.6% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.